Diana M. Cittelly - Concepedia

Author

Diana M. Cittelly

University of Colorado Anschutz Medical Campus ORCID

Also Known As

D M Cittelly, D. Cittelly, D. P. Junior, Dhanya K. P. Dhanya K. P., Diana Cittelly, Diana M Cittelly, Diana M Cittelly P, Diana M. Cittelly, Diana M. Cittelly Piñeros, Diana Marcela Cittelly

131

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Anschutz Medical Campus University of Colorado Denver The University of Texas Medical Branch at Galveston National Cancer Institute University of Colorado Cancer Center

About

Diana M. Cittelly is an author at University of Colorado Anschutz Medical Campus specializing in medicine, cell biology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	798
2	Cell Biology	8	8	779
3	Health Sciences	2	2	91
4	Engineering	1	1	133
5	Biomedical Engineering	1	1	18

Diana M. Cittelly

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide Dawn R. Cochrane, Sebastián Bernales, Britta M. Jacobsen, Breast Cancer Research	2014	391
Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen Heather M. Brechbuhl, Jessica Finlay-Schultz, Tomomi M. Yamamoto, Clinical Cancer Research	2016	227
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors Diana M. Cittelly, Partha Das, Nicole S. Spoelstra, Molecular Cancer	2010	186
Oncogenic HER2Δ16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumors Diana M. Cittelly, Partha Das, Virgilio A. Salvo, Carcinogenesis Breast OncologyEstrogen ReceptorCancer BiologyTamoxifen SensitivityBreast Tumors	2010	142
MicroRNAs Link Estrogen Receptor Alpha Status and Dicer Levels in Breast Cancer Dawn R. Cochrane, Diana M. Cittelly, Erin N. Howe, Hormones and Cancer Breast OncologyEngineeringDicer LevelsEndocrine-related CancerMedicine	2010	133
Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4 Diana M. Cittelly, Jessica Finlay-Schultz, Erin N. Howe, Oncogene Mir-29 Potentiates DedifferentiationBreast OncologyMedicineBreast Cancer CellsProgestin Suppression	2012	124
Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel Diana M. Cittelly, Irina Dimitrova, Erin N. Howe, Molecular Cancer Therapeutics Endocrine-related CancerMedicineTumor BurdenTumor ImmunityGynecology	2012	124
Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases María J. Contreras‐Zárate, Nicole L. Day, D. Ryan Ormond, Oncogene	2019	104
Activation of Wnt signaling promotes olaparib resistant ovarian cancer Tomomi M. Yamamoto, Alexandra McMellen, Zachary L. Watson, Molecular Carcinogenesis	2019	97
Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island Ping I. Hsu, Il‐Ran Hwang, Diana M. Cittelly, The American Journal of Gastroenterology	2002	92

Page 1